Table 3.
Treatment Duration and Best Response.
Treatment Course | Median (range) |
---|---|
All Diagnoses | N=39 |
Cycles to best response | 2 (1-11) |
Cycles to progression | 4 (1-46) |
Cycles on therapy | 4 (1-46) |
Time to death (days) | 290 (35-1419) |
Bone Sarcomas | N=21 |
Cycles to best response | 2 (1-11) |
Cycles to progression | 6 (2-46) |
Cycles on therapy | 7 (1-46) |
Time to death (days) | 385 (97-845) |
Best Response | N (%) |
All Diagnoses | N=39 |
Complete Response | 1 (2.6%) |
Partial Response | 2 (5.1%) |
Stable Disease | 20 (51.3%) |
Progressive Disease | 16 (41%) |
Bone Sarcomas | N=21 |
Complete Response | 1 (4.7%) |
Partial Response | 1 (4.7%) |
Stable Disease | 14 (66.7%) |
Progressive Disease | 5 (23.9%) |